{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:23:39Z","timestamp":1787315019988,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/jcp.0b013e31824858f7","type":"journal-article","created":{"date-parts":[[2012,3,4]],"date-time":"2012-03-04T00:02:23Z","timestamp":1330819343000},"page":"298-299","source":"Crossref","is-referenced-by-count":7,"title":["Bupropion XL for the Sustained Treatment of Trichotillomania"],"prefix":"10.1097","volume":"32","author":[{"given":"Kimberly Gottlieb","family":"Klipstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biopsych.2007.05.019","article-title":". Systematic review: pharmacological and behavioral treatment for trichotillomania.","volume":"62","author":"Bloch","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"R2-31-20210128","first-page":"123","article-title":"Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania.","volume":"53","author":"Stein","year":"1992","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R3-31-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNF.0b013e3181c8764f","article-title":"Oxcarbazepine for the treatment of trichotillomania.","volume":"33","author":"Leombruni","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R4-31-20210128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00005053-199610000-00011","article-title":". Serotonergic drugs in trichotillomania: treatment results in 12 patients.","volume":"184","author":"Iancu","year":"1996","journal-title":"J Nerv Ment Dis"},{"issue":"9","key":"R5-31-20210128","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.4088\/JCP.v65n0918c","article-title":"Alternative pharmacotherapy for trichotillomania: a report of successful bupropion use.","volume":"65","author":"Bhanjii","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R6-31-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0887-6185(99)00028-6","article-title":". Personal toll of trichotillomania: behavioral and interpersonal sequelae.","volume":"14","author":"Townsley-Stemberger","year":"2000","journal-title":"J Anxiety Disord"},{"key":"R9-31-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cpr.2009.10.008","article-title":". Trichotillomania: a current review.","volume":"30","author":"Duke","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"R10-31-20210128","first-page":"2","article-title":"Tourettes syndrome, trichotillomania, and obsessive-compulsive disorder: how closely are they related Psychiatry Res.","volume":"170","author":"Ferrao","year":"2009","journal-title":""},{"key":"R11-31-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00004714-199512000-00012","article-title":"Naltrexone for the treatment of trichotillomania: a case report.","volume":"15","author":"Carrion","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"R12-31-20210128","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.","volume":"66","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"R13-31-20210128","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/j.1460-9568.2007.05546.x","article-title":"Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.","volume":"25","author":"Paterson","year":"2007","journal-title":"Eur J Neurosci"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e31824858f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:40:24Z","timestamp":1786048824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201204000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31824858f7","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}